Home CGT Industrial Upgrade Park Tour Series: Nanjing Biopharma Valley – A Hub of Innovation Preparing for IPO

CGT Industrial Upgrade Park Tour Series: Nanjing Biopharma Valley – A Hub of Innovation Preparing for IPO

Jan 05, 2024 17:07 CST Updated 17:07
Yeasen

Tool Enzyme Raw Materials and Diagnostic Product R&D, Manufacturer

VectorBuilder

Gene Delivery Technology Developer

Life Biosciences

Experimental Animal Research Service Provider

Danaher

Product Design and Manufacturer

Legend Capital

Early-stage venture capital and growth-stage private equity investment institutions

1月江苏园区行_南京站.jpg


Event Information


■ Third Stop: Nanjing Biopharmaceutical Valley


Activity TimeJanuary 23, 2024 (Tuesday) 13:30

VenueActivity Report Hall, 1st Floor, BioMatrix Center, Building 13, Block 16, Treehouse, No. 73 Tanmi Road, Jiangbei New District, Nanjing

Host OrganizationHealthcare Innovative Ecosystem Alliance (HIEA)

Co-organized byHangzhou Xingcheng Biotechnology Co., Ltd., Yeasen, LePure Introduction, Austar, VectorBuilder, Life Biosciences, Danaher Corporation, Legend Capital

OrganizerArtery New Medicine



In November 2023, VCBeat's New Medicine collaborated with CGT industry chain enterprises to host a series of events on CGT industry upgrading in two parks: Zhangjiang, Shanghai, and FTZ One. The event invited decision-makers from innovative CGT companies and service providers within the industry chain to share needs, express genuine thoughts, promote communication, foster connections, and co-create quality products.


Recently, the U.S. FDA has been paying significant attention to CMC-related issues of cell therapy products, even affecting the progress of clinical trials; addressing CMC issues cannot be overlooked. Additionally, with the capital winter yet to thaw, how to secure financing, expand overseas, and survive has become a challenge for all innovative companies.


Based on this, by"Third Stop: [No Need to Struggle, Go Further] CGT Industry Upgrade Series · Park Tour," hosted by the Healthcare Innovative Ecosystem Alliance (HIEA) and co-organized by Hangzhou Xingcheng Biotechnology, Yeasen, LePure, Hong Kong Austar Group, VectorBuilder, Life Biosciences, Danaher Life Sciences, and Legend Capital, will be held at Nanjing Biomedicine Valley on January 23rd (Tuesday). The event is organized by VCBeat.


Share Highlights


CGT from an Investment Perspective: Investment Strategies for Innovative Drugs from an Investment Perspective, Providing Development Suggestions for Innovative Pharmaceutical Companies.


Optimal Supply Chain Solution: Listen to the needs of Party A, supply chain enterprises jointly explore the most suitable solutions, and strive to help innovative companies move smoothly, quickly, and cost-effectively from IND to BLA.


Overseas Strategy Insights: More specific opportunities for going global in Southeast Asia, pharmaceutical registration applications in Islamic regions, are highly referential for all enterprises about to expand overseas.


This "Nanjing Biopharmaceutical Valley Tour" is the third stop in the series of park tours. In the future, similar events will be held in other parks to promote the continuous upgrading and development of the CGT industry. We look forward to discussing and making progress together with our peers in the industry, helping the CGT industry go further!


Agenda


■ 13:30-13:35 Host Opening + Ecosystem Introduction

Host | Event Expectations and Ecosystem Collaboration


■ 13:35-13:40  Speech by Park Leadership


■ 13:40-14:00

Keynote Speech 1 |Rotating Co-organizer Theme Sharing


■ 14:00-14:20

Keynote Speech 2 |Danaher Life Sciences Theme Sharing


■ 14:20-15:30

Panel 1 | How to Collaborate to Support CGT Companies from IND to BLA, Stably, Quickly, and Cost-effectively?

  • Introduction to Core Competencies and Service Value

  • How to Positively Interact with the Client in a Professional Manner and Collaborate for Mutual Benefit


■ 15:30-16:30

Panel 2 | Discussing Industrial Upgrading: Key Points and Solutions for Gene and Cell Therapy CMC

  • Not Broadly Discussing Regulations

  • Discuss Quality Control Strategies and Specific Service Cases

  • Party A presents the demands, Party B proposes the solutions.


■ 16:30-16:50 Tea Break


■ 16:50-17:10

Keynote Speech 3 |Progress and Trends in the CGT Industry from an Investment Perspective

  • Finance as a Tool: Understanding the Trends of the Capital Market

  • Industry as the Foundation: Current Status and Outlook of the CGT Industry


■ 17:10-17:30

Keynote Speech 4 |Southeast Asia Market Entry Strategies for Innovative Pharmaceutical Companies

  • Southeast Asia Overseas Strategy for Innovative Pharmaceutical Companies

  • Specific Opportunities in Southeast Asia

  • Pharmaceutical Registration in Islamic Regions

  • Overseas Cooperation Cases


■ 17:30-18:30

Panel 3 | In the New Situation, How Can CGT Enterprises Effectively "Raise and Spend Money"?

  • Farewell to Stereotypical Roadshows, Embrace Random Conversations

  • Insights and Reflections to Help Companies Showcase Value

  • "Get Ready" and Respect Uncertainty

  • Innovative One-to-Many Interview-Style Project Promotion


■ 18:30-20:30 Dinner Gathering


Event Scale: 50 people/session

Activity Cooperation:

Ms. Fu 17851017836 (Same number for WeChat)

Event Registration:

Capillary 17782369627 (Same for WeChat)

Scan to Register

微信图片_20240105163150.jpg


1月园区行-议程海报_南京站.jpg